logo.jpg

Aimedis (AIMX), An Ehealth Platform Based On Blockchain Tech…

(MENAFN– TimesNewswire )

BitMart, a premier global digital asset trading platform, will list Aimedis (AIMX) on August 29, 2022. For all BitMart users, the AIMX/USDT trading pair will be officially available for trading and staking at 09:00 AM (UTC).



What is Aimedis (AIMX) ?

Aimedis – an eHealth platform based on blockchain technology, which has been developed since 2017 and released in the current version 2020 for web, iOS and Android. Aimedis combines eHealth applications such as health records, video chat with doctors, appointments, prescriptions, second opinions, wearables, a hospital and practice information system, emergency records and much more along with medical social media platform, eLearning, eTeaching and education, a unique medical and scientific-pharmaceutical NFT data marketplace, while displaying all relevant operations in a private blockchain, visible and transparent for the patient.

Why Choose Aimedis (AIMX)?

Aimedis builds the world’s first medical, scientific and wellness metaverse and opens the world’s first virtual hospital chain in the metaverse while offering space to other hospitals, companies, universities and people. Aimedis Avalon (the name of the metaverse) offers therapies, consultations, research, education, social interaction, safe spaces, speakers corners and a complete healthcare economy on the blockchain.

The Aimedis token, which is tailored to the platform, is much more than just utility and payment tokens, it also offers staking, governance, DeFi (the first medical DeFi token) and the next hot trend in the field of cryptocurrencies, social token functionalities. The Aimedis NFTs are a revolutionary tool for medical data along with functionalities inside the Aimedis metaverse.

The Aimedis DApp aimx.aimedis.io offers users staking options up to 30% APY, Farming and you can also buy land in the Avalon Metaverse. There are already 3 Cities- Dubai, Singapore and Lausanne. Tokyo will be available shortly.

Vision

  • Give back trust.
  • Time has come to finally empower the patients all over the world.
  • Give control and full transparency to the people affected.
  • Offer affordable medical support and services even for 3rd world countries while at the same time.
  • Optimizing healthcare in industrial countries that suffer from unconnected, expensive and siloed healthcare systems.
  • Break and cross borders-people travel and are less and less bound to a specific location while Aimedis is always at their side.
  • Aimedis created an open system that is not once again a closed silo that

needs specific hardware and excludes people.

About BitMart

BitMart Exchange is a premier global digital assets trading platform with over 9 million users worldwide and ranked among the top crypto exchanges on CoinMarketCap . BitMart currently offers 1000+ trading pairs with one of the lowest trading fees in the market. To learn more about BitMart, visit their Website , follow their Twitter , or join their Telegram for more updated news and promotions. Download BitMart App to trade anytime, anywhere.

About Aimedis (AIMX)

Aimedis is designed to support the work of professionals as well as the treatment of

patients. Partnering hospitals, caregivers insurances and other companies can hold AIMX token at a certain value in a wallet Based on that they can use the Aimedis services which then generates a steady income by the participants.

To learn more about Aimedis (AIMX), please visit their Website , follow their Twitter and join their Telegram .

BitMart Social Media

English Telegram | Asia Telegram |  BitMart Exchange Twitter I

BitMart Research Twitter | BitMart Homepage | BitMart App   I

Sign up on BitMart, and start trading today!

MENAFN27082022006250013577ID1104767031


Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.


Source link

Tags: No tags

Add a Comment

Your email address will not be published. Required fields are marked *